In a similar experiment, glioma stem cell survival was significantly reduced in vitro after combined RT and a GSI (DAPT or L685.458) and in vivo after combining RT and Notch1/2 shRNA knockdown, as compared to individual treatments. The gene discussed is NOTCH1; the disease is central nervous system cancer.